insights_auto
Why is ORX down 2,62%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,85 SEK
arrow_downward
-2,62%(-0,023) 1D
16 ნოე, 14:02:07 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
298,96 მლნ.
Avg. vol.
777,72 ათ.
Volume
297,88 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
298,96 მლნ.
Avg. vol.
777,72 ათ.
Volume
297,88 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
24/7 Wall St.
·
19 წუთის წინ
2 Safe S&P 500 Financial Dividend Stocks Boomers Can Buy and Hold Forever
Business Insider
·
2 საათის წინ
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Investing.com
·
1 საათის წინ
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
www.tokenpost.com
·
26 წუთის წინ
S&P 500 and Nasdaq 100 Futures Extend Declines to Quarterly Lows
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com